Infection and preterm birth

American Journal of Perinatology

Volumn 17, Issue 7, 2000, Pages 357-365

  Andrews, W W ^a   Hauth, J C ^a   Goldenberg, R L ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Genital tract infection; Low birth weight; Preterm birth

Indexed keywords

ANTIBIOTIC THERAPY; ARTICLE; DISEASE MARKER; GENITAL TRACT INFECTION; INFANT MORTALITY; INFECTION; MORBIDITY; NEUROLOGIC DISEASE; PATHOPHYSIOLOGY; PREMATURITY; PRIORITY JOURNAL; UNITED STATES; VAGINA FLORA; VAGINITIS; VERY LOW BIRTH WEIGHT;

FEMALE; HUMANS; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RANDOMIZED CONTROLLED TRIALS; VAGINOSIS, BACTERIAL;

EID: 0034537003     PISSN: 07351631     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-13448     Document Type: Article

References (54)

1. Outcomes of extremely immature infants: A perinatal dilemma
2. Report of final natality statistics, 1995
3. Neonatal mortality rate: Is further improvement possible?
4. The economics of preterm delivery
5. Conceptualizing categories of preterm birth
6. Intrauterine viral infection at the time of second trimester genetic amniocentesis is not associated with post-procedure pregnancy loss
7. Unrecognized amnionitis and prematurity: A preliminary report
8. Preterm labor: Emerging role of genital tract infections
9. Infection-related risk factors predictive of spontaneous preterm birth
10. Infection and preterm labor
11. A review of premature birth and subclinical infection
12. Chorioamnion colonization: Correlation with gestational age in women following spontaneous versus indicated delivery
13. The association of occult amniotic fluid infection with gestational age and neonatal outcome among women in preterm labor
14. Amniotic fluid interleukin-6: Correlation with upper genital tract microbial colonization and gestational age in women delivered after spontaneous labor versus indicated delivery
15. Mechanisms of disease: Intrauterine infection and pre-term birth
16. Elevated amniotic fluid interleukin-6 levels at genetic amniocentesis predict subsequent pregnancy loss
17. Elevated second trimester amniotic fluid interleukin-6 levels predict preterm delivery
18. Plasma cell endometritis in women with symptomatic bacterial vaginosis
19. Endometrial microbial colonization and plasma cell endometritis are common three months postpartum
20. Bacterial vaginosis: Association with adverse pregnancy outcome
21. Non-specific vaginitis: Diagnostic and microbial and epidemiological associations
22. Bacterial vaginosis
23. Reliability of diagnosing bacterial vaginosis by a standardized method of Gram stain interpretation
24. The genital flora of women with intraamniotic infection: Vaginal infection and prematurity study group
25. Evidence relating bacterial vaginosis to intraamniotic infection
26. The role of bacterial vaginosis and vaginal bacteria in amniotic fluid infection in women in preterm labor with intact fetal membranes
27. The pre-term prediction study: Significance of vaginal infections
28. Midtrimester threshold vaginal pH and Gram stain scores predictive of subsequent preterm birth
29. Markers of preterm birth
30. Prediction of prematurity
31. Toward a multiple marker test for spontaneous pre-term birth
32. The preterm prediction study: Early fetal fibronectin testing predicts early spontaneous preterm birth
33. Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery
34. Is oncofetal fibronectin a tropboblast glue for human implantation?
35. Fetal fibronectin as a predictor of preterm birth in symptomatic patients: A multicenter trial
36. The preterm prediction study: Fetal fibronectin, bacterial vaginosis and peripartum infection
37. The preterm prediction study: Quantitative fetal fibronectin values and the prediction of spontaneous preterm birth
38. Quantitative fetal fibronectin levels and the prediction of spontaneous preterm birth in symptomatic women
39. Use of antibiotics to prevent preterm birth
40. Ampicillin and metronidazole treatment in preterm labor: A multicenter, randomized controlled trial
41. Ampicillin-metronidazole treatment in idiopathic pre-term labour: A randomized controlled multicentre trial
42. Intravaginal clindamycin treatment for bacterial vaginosis: Effects on preterm delivery and low birth weight
43. Prophylactic administration of clindamycin 2% vaginal cream to reduce the incidence of spontaneous preterm birth in women with an increased recurrence risk: A randomized placebo-controlled double-blind trial
44. Bacterial vaginosis is associated with prematurity and vaginal fluid and sialidase: Results of a controlled trial of topical clindamycin cream
45. Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: A placebo-controlled, double-blind study
46. Reduced incidence of preterm delivery, with metronidazole and erythromycin in women with bacterial vaginosis
47. Impact of metronidazole therapy on preterm birth in women with bacterial vaginosis flora (Gardnerella vaginalis): A randomized, placebo controlled trial
48. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis
49. Maternal infection and cerebral palsy in infants of normal birth weight
50. Neonatal cytokines and coagulation factors in children with cerebral palsy
51. Intramniotic inflammation and the development of cerebral palsy at three years of age
52. Elevated umbilical cord interleukin-6 (IL-6) after preterm birth (PTB) is associated with adverse neonatal outcomes including systemic inflammatory response syndrome (SIRS)
53. Microbial invasion of the chorioamnion and histologic chorioamnionitis are associated with systemic inflammatory response syndrome in preterm neonates
54. Metronidazole treatment increased the risk of preterm birth in asymptomatic women with trichomonas